Hyam Levitsky
2016
In 2016, Hyam Levitsky earned a total compensation of $2.1M as Executive Vice President, Research and Chief Scientific Officer at Juno Therapeutics, a 85% decrease compared to previous year.
Compensation breakdown
| Bonus | $28,000 |
|---|---|
| Non-Equity Incentive Plan | $131,840 |
| Option Awards | $1,534,750 |
| Salary | $390,692 |
| Other | $43,864 |
| Total | $2,129,146 |
Levitsky received $1.5M in option awards, accounting for 72% of the total pay in 2016.
Levitsky also received $28K in bonus, $131.8K in non-equity incentive plan, $390.7K in salary and $43.9K in other compensation.
Rankings
In 2016, Hyam Levitsky's compensation ranked 4,603rd out of 14,075 executives tracked by ExecPay. In other words, Levitsky earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,603 out of 14,075 | 67th |
Division Manufacturing | 1,630 out of 5,488 | 70th |
Major group Chemicals And Allied Products | 506 out of 1,900 | 73rd |
Industry group Drugs | 374 out of 1,543 | 76th |
Industry Biological Products, Except Diagnostic Substances | 68 out of 287 | 76th |
Source: SEC filing on April 21, 2017.
Levitsky's colleagues
We found four more compensation records of executives who worked with Hyam Levitsky at Juno Therapeutics in 2016.